Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Net Equity Issued and Repurchased (2011 - 2019)

Amarin Corp Plc\Uk (AMRN) posted quarterly Net Equity Issued and Repurchased of -$837000.0 for Q4 2019, down 100.43% year-over-year from $194.8 million in Q4 2018, and down 100.19% quarter-over-quarter from $440.1 million in Q3 2019.

Amarin Corp Plcuk (AMRN) Net Equity Issued and Repurchased (2011 - 2019) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Net Equity Issued and Repurchased for 4 consecutive years, with -$837000.0 the latest figure, recorded in Q4 2019.

  • In Q4 2019, Net Equity Issued and Repurchased fell 100.43% year-over-year to -$837000.0; the TTM figure through Sep 2022 stood at -$837000.0 (down 100.19% YoY), while the FY2019 annual figure was $440.1 million, up 66.18% from the prior year.
  • Net Equity Issued and Repurchased eased to -$837000.0 in Q4 2019 per AMRN's latest filing, from $440.1 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $440.1 million in Q3 2019 and bottomed at -$837000.0 in Q4 2019.
  • Historically, Net Equity Issued and Repurchased has averaged $100.6 million across 3 years, with a median of $423000.0 in 2018.
  • On a YoY basis, Net Equity Issued and Repurchased climbed as much as 104144.44% in 2019 and fell as far as 100.43% in 2019.
  • Amarin Corp Plc\Uk's Net Equity Issued and Repurchased stood at -$1000.0 in 2016, then surged by 19483400.0% to $194.8 million in 2018, then slumped by 100.43% to -$837000.0 in 2019.
  • Business Quant data shows AMRN's Net Equity Issued and Repurchased at -$837000.0 in Q4 2019, $440.1 million in Q3 2019, and $194.8 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 9.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -837,000.00
Dec 31, 2019 -837,000.00
Sep 30, 2019 440.11 Mn
Sep 30, 2019 440.11 Mn
Dec 31, 2018 194.83 Mn
Dec 31, 2018 194.83 Mn
Sep 30, 2018 -423,000.00
Sep 30, 2018 -423,000.00
Jun 30, 2018 423,000.00
Jun 30, 2018 423,000.00
Mar 31, 2018 70.01 Mn
Mar 31, 2018 70.01 Mn
Dec 31, 2016 -1,000.00
Dec 31, 2016 -1,000.00
Jun 30, 2011 -17,000.00
Jun 30, 2011 -17,000.00
Mar 31, 2011 98.67 Mn
Mar 31, 2011 98.67 Mn